453 related articles for article (PubMed ID: 24297641)
21. Systemic lupus erythematosus patients with past neuropsychiatric involvement are associated with worse cognitive impairment: a longitudinal study.
Gao Y; Lau EY; Wan JH; Lau CS; Mok MY
Lupus; 2016 May; 25(6):637-44. PubMed ID: 26700182
[TBL] [Abstract][Full Text] [Related]
22. Mania occurring during systemic lupus erythematosus relapse and its amelioration on clinical and neuroimaging follow-up.
Hirachi T; Ishii H; Tada Y; Noguchi T; Haraguchi Y; Tateishi H; Mizoguchi Y; Kato TA; Kawashima T; Monji A
Lupus; 2015 Aug; 24(9):990-3. PubMed ID: 25661832
[TBL] [Abstract][Full Text] [Related]
23. [Psychotic disorder in the course of Systemic Lupus Erythematosus with subcortical calcifications--case report].
Malec M; Malec M; Rudzińska M; Dudek D; Siwek M; Wnuk M; Szczudlik A
Psychiatr Pol; 2014; 48(2):299-306. PubMed ID: 25016767
[TBL] [Abstract][Full Text] [Related]
24. Neuropsychiatric systemic lupus erythematosus among Nigerians.
Adelowo OO; Oguntona AS; Ojo O
Afr J Med Med Sci; 2009 Mar; 38(1):33-8. PubMed ID: 19722426
[TBL] [Abstract][Full Text] [Related]
25. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
[TBL] [Abstract][Full Text] [Related]
26. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
Meinão IM; Sato EI; Andrade LE; Ferraz MB; Atra E
Lupus; 1996 Jun; 5(3):237-41. PubMed ID: 8803897
[TBL] [Abstract][Full Text] [Related]
27. Antimalarials in the treatment of systemic lupus erythematosus: a registry-based cohort study in Denmark.
Nørgaard JC; Stengaard-Pedersen K; Nørgaard M; de Thurah A
Lupus; 2015 Mar; 24(3):299-306. PubMed ID: 25318969
[TBL] [Abstract][Full Text] [Related]
28. Psychosis Unmasking a Diagnosis of Systemic Lupus Erythematosus: a Case Report.
Kumari S; Nath S; Narasimha VL; Sarkar M; Kumar R
East Asian Arch Psychiatry; 2023 Sep; 33(3):100-103. PubMed ID: 37771217
[TBL] [Abstract][Full Text] [Related]
29. [Mood disorder after malaria prophylaxis with mefloquine (two case reports)].
Oueriagli Nabih F; Touhami M; Laffinti A; Abilkacem L
Encephale; 2011 Oct; 37(5):393-6. PubMed ID: 22032283
[TBL] [Abstract][Full Text] [Related]
30. Case Report: Psychopathological Syndromes in the Course of Lupus Erythematosus and the Co-occurrence of Lupus Erythematous With Mental Disorders.
Stelmach E; Masiak J
Front Psychiatry; 2021; 12():668050. PubMed ID: 34248705
[No Abstract] [Full Text] [Related]
31. Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE.
Shimizu Y; Yasuda S; Kako Y; Nakagawa S; Kanda M; Hisada R; Ohmura K; Shimamura S; Shida H; Fujieda Y; Kato M; Oku K; Bohgaki T; Horita T; Kusumi I; Atsumi T
Autoimmun Rev; 2016 Aug; 15(8):786-94. PubMed ID: 27016478
[TBL] [Abstract][Full Text] [Related]
32. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population--a preliminary report.
Bogaczewicz A; Sobow T; Bogaczewicz J; Kaleta B; Sysa-Jedrzejowska A; Robak E; Lukaszkiewicz J; Dariusz S; Wozniacka A
Lupus; 2013 Dec; 22(14):1504-8. PubMed ID: 24243911
[TBL] [Abstract][Full Text] [Related]
34. Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients.
Wozniacka A; Lesiak A; Narbutt J; McCauliffe DP; Sysa-Jedrzejowska A
Lupus; 2006; 15(5):268-75. PubMed ID: 16761500
[TBL] [Abstract][Full Text] [Related]
35. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
[TBL] [Abstract][Full Text] [Related]
36. Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria.
Esteve-Valverde E; Tapiz-Reula A; Ruiz D; Alijotas-Reig J
Rheumatol Int; 2020 May; 40(5):777-783. PubMed ID: 31865445
[TBL] [Abstract][Full Text] [Related]
37. Patients opinion and adherence to antimalarials in lupus erythematosus and rheumatoid arthritis treatment.
Cabral RTS; Klumb EM; Carneiro S
J Dermatolog Treat; 2020 May; 31(3):264-269. PubMed ID: 30935255
[No Abstract] [Full Text] [Related]
38. Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
Lesiak A; Narbutt J; Sysa-Jedrzejowska A; Lukamowicz J; McCauliffe DP; Wózniacka A
Lupus; 2010 May; 19(6):683-8. PubMed ID: 20064914
[TBL] [Abstract][Full Text] [Related]
39. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
[TBL] [Abstract][Full Text] [Related]
40. [Eye toxicity of antimalarial agents].
Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
